Results 71 to 80 of about 369,068 (270)

Time Trends and Predictors of Gout Remission Over 6 Years

Arthritis Care &Research, EarlyView.
Objective This study aims to describe the trends in remission rates over 6 years of follow‐up among people with gout taking urate‐lowering therapy (ULT) and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES) trial ...
Adwoa Dansoa Tabi‐Amponsah, Sarah Stewart, Greg Gamble, Lisa K. Stamp, William J. Taylor, Nicola Dalbeth   +5 more
wiley   +1 more source

Penalized generalized estimating equations for relative risk regression with applications to brain lesion data [PDF]

, 2021
Petya Kindalova, Michele Veldsman, Thomas E. Nichols, Ioannis Kosmidis   +3 more
openalex   +1 more source

Nurse Staffing Level and Nosocomial Infections: Empirical Evaluation of the Case-Crossover and Case-Time-Control Designs [PDF]

, 2017
The authors compared a case-crossover design, a case-time-control design, and a cohort design to evaluate the effect of nurse staffing level on the risk of nosocomial infections.
Hugonnet, Stéphane, Pittet, Didier, Villaveces, Andrés   +2 more
core  

Proportion of Acceptable Symptom State Nearly Tripled With Improvements in Patient‐Reported Outcomes for All Symptom State Subgroups: A Registry Study of More Than 15,000 Patients With Osteoarthritis in Digital Education and Exercise Therapy

Arthritis Care &Research, EarlyView.
Objective This study investigated trajectories of patient acceptable symptom state (PASS) among participants of digital education and exercise therapy for knee and hip osteoarthritis. Methods A longitudinal observational study among individuals aged at least 40 years who participated in the digital program.
Ali Kiadaliri, L. Stefan Lohmander, Amanda E. Nelson, Leif E. Dahlberg   +3 more
wiley   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

A Posteriori Error Estimates for Fully Discrete Finite Element Method for Generalized Diffusion Equation with Delay [PDF]

, 2020
Wansheng Wang, Lijun Yi, Aiguo Xiao
openalex   +1 more source

The New Keynesian Phillips curve : lessons from single-equation econometric estimation [PDF]

We review single-equation methods for estimating the hybrid New Keynesian Phillips curve (NKPC) and then apply those methods to U.S. quarterly data for 1955?2007.
Gregor W. Smith, James M. Nason
core  

Treating lupus nephritis patients to lupus low disease activity reduces renal relapse and preserves long‐term kidney function

Arthritis Care &Research, Accepted Article.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond YH Yap, KL Lee, Philip H Li, Iris YK Tang, Chak Sing Lau, Shirley CW Chan   +6 more
wiley   +1 more source

Investigation of the Temperature Dependence of Parameters in the Generalized Peukert Equation Used to Estimate the Residual Capacity of Traction Lithium-Ion Batteries [PDF]

, 2022
Nikolay E. Galushkin, Nataliya N. Yazvinskaya, Dmitriy N. Galushkin   +2 more
openalex   +1 more source

Endogenous Costs and Price-Cost Margins [PDF]

Empirical work on price-cost margins often treats costs as exogenous. Allowing for endogenous costs when estimating price-cost margins is the topic of this paper. Methodologically, the endogenous cost model we propose leads to an additional equation that
Damien J. Neven, Lars-Hendrik Röller, Zhentang Zhang   +2 more
core